TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).

Michael B Atkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.